Schizophrenia: Gender, family risk, and plasma homovanillic acid

✍ Scribed by Dávila, Ricardo ;Zumárraga, Mercedes ;González-Torres, Miguel A. ;Andía, Isabel ;Zamalloa, Maria I. ;Basterreche, Edurne ;Guimón, José ;Friedhoff, Arnold J.

• Publisher: John Wiley and Sons
• Year: 1995
• Tongue: English
• Weight: 323 KB
• Volume: 60
• Category: Article
• ISSN: 0148-7299
• DOI: 10.1002/ajmg.1320600213

✦ Synopsis

Plasma homovanillic acid concentration was assessed in 60 young schizophrenic patients, with and without first-degree relatives with schizophrenia, before treatment, and 3 days after starting haloperidol treatment. The baseline concentration of homovanillic acid in plasma was no different in the two groups before treatment; it was, however, significantly higher in the patients with relatives than in those without relatives diagnosed of schizophrenia after 3 days of haloperidol treatment.